✦ LIBER ✦

A Prospective, Open-Label Safety and Efficacy Study of Combination Treatment with Bortezomib (PS-341, Velcade™) and Melphalan in Patients with Relapsed or Refractory Multiple Myeloma

✍ Scribed by Yang, Hank H.; Vescio, Robert; Schenkein, David; Berenson, James R.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Prospective, Open-Label Safety and Eff

✍ Berenson, James R.; Swift, Regina A.; Ferretti, Delina; Purner, Matthew B. 📂 Article 📅 2004 🏛 CIG Media Group, LP. 🌐 English ⚖ 99 KB

Safety and efficacy of bortezomib and me

✍ James R. Berenson; Hank H. Yang; Robert A. Vescio; Youram Nassir; Russell Mapes; 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 164 KB

Weekly bortezomib in combination with te

✍ Irene M Ghobrial; Edie Weller; Ravi Vij; Nikhil C Munshi; Ranjit Banwait; Meghan 📂 Article 📅 2011 🏛 The Lancet 🌐 English ⚖ 210 KB

Tanespimycin and bortezomib combination

✍ Paul G. Richardson; Asher A. Chanan-Khan; Sagar Lonial; Amrita Y. Krishnan; Mich 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 382 KB

Phase I/II Trial Assessing Bortezomib an

✍ Berenson, J. R. 📂 Article 📅 2006 🏛 American Society of Clinical Oncology 🌐 English ⚖ 103 KB

Efficacy and safety of melphalan, arseni

✍ James R. Berenson; Ralph Boccia; David Siegel; Marek Bozdech; Alberto Bessudo; E 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 573 KB